Study of vitamin D level in acute coronary syndrome | ||||
SVU-International Journal of Medical Sciences | ||||
Article 46, Volume 5, Issue 2, July 2022, Page 470-483 PDF (300.29 K) | ||||
Document Type: Original research articles | ||||
DOI: 10.21608/svuijm.2022.152160.1350 | ||||
![]() | ||||
Authors | ||||
Yasser M. Kamal ![]() | ||||
Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag82545, Egypt | ||||
Abstract | ||||
Background: Vitamin D (Vit. D) insufficiency is thought to play a role in the prognosis of some cardiovascular diseases (CVDs) and other comorbidities such as Diabetes millets (DM), chronic kidney disease (CKD), obesity, and hypertension. In heart failure (HF) cases, Vit. D supplementation is associated with bettered survival. Furthermore, Vit. D supplementation decreased mortality rates in critical medical situations, such as end-stage renal disease (ESRD) and coronary artery disease (CAD). Objectives:The current study aimed to assess Vit. D levels in cases present with the acute coronary syndrome (ACS). Patients and Methods: 60 ACS patients and 30 healthy individuals were recruited for the current study. All participants passed a clinical-based cross-sectionalstudy, at SohagUniversity hospital within six months (From March to September 2019 for vit. D levels and other laboratory measures. Results: In this study,16.6 % of ACS cases were Vit. D deficient, compared to 10% of control. 45%of ACS cases were Vit. D inadequate, compared to26.6% of control (P= 0.001). Conclusion: Since Vit. D insufficiency is a potentially modifiable threat factor in CVDs patients, hence a persistent need to consider in diagnosis and treatment. ACS patients with estimated Vit. D deficiency or insufficiency should be advised with Vit. D supplementations. Vit. D issues should be bandied with the family members from a moment’s perspective. | ||||
Keywords | ||||
Vit. D; acute coronary syndrome; Sohag University Hospital | ||||
Statistics Article View: 283 PDF Download: 258 |
||||